今年以来,生物医药板块已成为了今年来A股和港股市场中股价翻倍最多的板块。基于行业趋势和业务突破双重获益,深耕糖尿病治疗领域的创新药企华领医药(02552)年初至今股价已翻倍,并于7月22日创下年内新高,达到4.17港元。事实上,华领医药股价的走高正是本轮港股创新药牛市的具象化体现。尽管近日出现技术性波动,但整体走势来看,华领的股价与市值依旧未触及本轮行情顶点,仍有巨大的持续走高空间。原因在于,与上...
Source Link今年以来,生物医药板块已成为了今年来A股和港股市场中股价翻倍最多的板块。基于行业趋势和业务突破双重获益,深耕糖尿病治疗领域的创新药企华领医药(02552)年初至今股价已翻倍,并于7月22日创下年内新高,达到4.17港元。事实上,华领医药股价的走高正是本轮港股创新药牛市的具象化体现。尽管近日出现技术性波动,但整体走势来看,华领的股价与市值依旧未触及本轮行情顶点,仍有巨大的持续走高空间。原因在于,与上...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.